Results 251 to 260 of about 58,806 (288)

Clinical Features, Outcomes, and Antifungal Susceptibility Profiles of Invasive <i>Candida</i> Infections in a Tertiary Care Hospital in China. [PDF]

Infect Drug Resist
Yao D, Chen J, Zhang G.
europepmc   +1 more source

The first prevalence and antifungal susceptibility profile of Candida infections in Palestine, 2022. [PDF]

BMC Infect Dis
Baniodeh H, Abu-Helu R, Abulihya M, Awwad MY, Dawoud A, Tebbji F, Sellam A.   +6 more
europepmc   +1 more source

Maize Knows Friends or Foes? The Dark Side of Trichoderma asperellum as a Maize Ear Rot Pathogenic Fungus

Plant Biotechnology Journal, EarlyView.
Weixiang Wang, Senlin Xiao, Fan Que, Liang Le, Aiguo Su, Zhihuan Zhou, Xiangzhang Zhu, Yanbing Zhang, Liyu Shi, Tao Zhong, Haixia Zhang, Jinfeng Xing, Min Lu, Ruyang Zhang, Ronghuan Wang, Wei Song, Jiuran Zhao   +16 more
wiley   +1 more source

AtMYB72 as a Biotechnological Tool to Overcome Phenylpropanoid Substrate Limitation and Enhance Coumarin Biosynthesis in Plants

Plant Biotechnology Journal, EarlyView.
Jakob Weber Böhlen, Alexander Beesley, Sebastian F. Beyer, Patrick Schwinges, Alina E. Maas, Holger Schultheiss, Uwe Conrath, Caspar J. G. Langenbach   +7 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antifungal Susceptibility Testing and Identification

Infectious Disease Clinics of North America, 2021
The requirement for antifungal susceptibility testing is increasing given the availability of new drugs, increasing populations of individuals at risk for fungal infection, and emerging multiresistant fungi. Rapid and accurate fungal identification remains at the forefront of laboratory efforts to guide empiric therapy.
Sarah E, Kidd, Lucy C, Crawford, Catriona L, Halliday   +2 more
openaire   +2 more sources

Antifungal Susceptibility Testing

Infectious Disease Clinics of North America, 2006
Antifungal susceptibility testing has been in routine use now for more than 15 years and has become a useful tool for clinicians who are faced with difficult treatment decision. Although most clinicians order susceptibility testing, much confusion still exists regarding the use of the results.
Annette W, Fothergill, Michael G, Rinaldi, Deanna A, Sutton   +2 more
openaire   +2 more sources

Antifungal Susceptibility Testing Methods

Current Drug Targets, 2005
The number of systemically active antifungal agents has increased dramatically in recent years in response to the challenge of invasive mycoses. Additional work is needed to better understand the mechanisms of action of these agents as well as the mechanisms of resistance expressed by the fungal pathogens.
openaire   +2 more sources

In Vitro Antifungal Susceptibility Testing

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
With the rising frequency of fungal infections, as well as increasing reports of resistance to antifungal agents, it is imperative that clinically applicable antifungal susceptibility testing be available. In 1997 the National Committee for Clinical Laboratory Standards published standard guidelines for antifungal susceptibility testing of Candida sp ...
H L, Hoffman, M A, Pfaller
openaire   +2 more sources